Ivabradine hydrochloride is a selective inhibitor of the If current in cardiac pacemaker cells, primarily indicated for the symptomatic treatment of chronic stable angina pectoris in patients with normal… Read more
Ivabradine hydrochloride is a selective inhibitor of the If current in cardiac pacemaker cells, primarily indicated for the symptomatic treatment of chronic stable angina pectoris in patients with normal sinus rhythm who are unable to tolerate beta-blockers. To support rigorous pharmaceutical analysis, this category features a comprehensive range of high-quality reference standards, including pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds. Laboratories utilize these materials for impurity profiling, method validation, and routine quality control of the active pharmaceutical ingredient. By providing consistent standards for degradants such as dehydro and N-demethyl impurities, as well as critical metabolites like hydroxy and 2-oxo forms, these compounds enable analysts to ensure the accuracy of analytical testing and compliance with regulatory standards. Accessing these specialized reference materials is essential for maintaining the safety and efficacy profiles of ivabradine hydrochloride drug products throughout the manufacturing and development lifecycle.
![Chemical structure of (3,4-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methanamine Hydrochloride](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F35202-55-2-34-Dimethoxybicyclo4.2.0octa-135-trien-7-ylmethanamine-Hydrochloride.png&w=3840&q=75)